Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Irritable Bowel Syndrome

Free Subscription Articles published in Aliment Pharmacol Ther Retrieve available abstracts of 78 articles: HTML format

Single Articles

April 2008
1. JARCHO JM , Chang L, Berman SM, Suyenobu B, et al
   Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT(3) receptor antagonist - a pilot study.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. MCNALLY MA , Locke GR, Zinsmeister AR, Schleck CD, et al
   Biliary events and an increased risk of new onset irritable bowel syndrome: A population-based cohort study.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. CHASSANY O , Matuchansky C
   Probiotics and the irritable bowel syndrome.
   Aliment Pharmacol Ther. 2008;27:616-7.
   PubMed     Related articles   
   
   
   February 2008
4. DUPONT HL
   Systematic review: prevention of travelers' diarrhea.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. GEORGE AM , Meyers NL, Hickling RI
   Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome - a multicentre, randomised, placebo-controlled, double-blind study in the primary healthcare setting.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
6. VAHEDI H , Merat S, Momtahen S, Kazzazi AS, et al
   Clinical trial: the effect of amitriptyline in patients with diarrhea-predominant irritable bowel syndrome.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. JOHANSON JF , Drossman DA, Panas R, Wahle A, et al
   Clinical trial: phase 2 trial of lubiprostone for irritable bowel syndrome with constipation.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. LOMER MC , Parkes GC, Sanderson JD
   Review article: lactose intolerance in clinical practice--myths and realities.
   Aliment Pharmacol Ther. 2008;27:93-103.
   PubMed     Related articles    Abstract available
   
   
   
9. NOJKOV B , Rubenstein J, Adlis S, Shaw M, et al
   Predictors of response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: the impact of co-morbidities on treatment outcomes and quality of life.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. AGRAWAL A , Whorwell PJ
    Review article: abdominal bloating and distension in functional gastrointestinal disorders--epidemiology and exploration of possible mechanisms.
    Aliment Pharmacol Ther. 2008;27:2-10.
    PubMed     Related articles    Abstract available
    
    
    December 2007
11. CHOUNG RS , Locke GR 3rd, Schleck CD, Zinsmeister AR, et al
    Cumulative incidence of chronic constipation: a population-based study 1988-2003.
    Aliment Pharmacol Ther. 2007;26.
    PubMed     Related articles    Abstract available
    
    
    
12. JONKERS D , Stockbrugger R
    Review article: Probiotics in gastrointestinal and liver diseases.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:133-48.
    PubMed     Related articles    Abstract available
    
    
    October 2007
13. LEVENTER SM , Raudibaugh K, Frissora CL, Kassem N, et al
    Clinical trial: dextofisopam in the treatment of patients with diarrhea-predominant or alternating irritable bowel syndrome.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. KAJANDER K , Myllyluoma E, Rajilic-Stojanovic M, Kyronpalo S S, et al
    Clinical trial: multispecies probiotic supplementation alleviates the symptoms of IBS and stabilises intestinal microbiota.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. SCHRODER O , Naumann M, Shastri Y, Povse N, et al
    Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Aliment Pharmacol Ther. 2007;26:1035-42.
    PubMed     Related articles    Abstract available
    
    
    
16. VAN KERKHOVEN LA , Laheij RJ, Jansen JB
    Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome.
    Aliment Pharmacol Ther. 2007;26:979-86.
    PubMed     Related articles    Abstract available
    
    
    September 2007
17. ERSRYD A , Posserud I, Abrahamsson H, Simren M, et al
    Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Aliment Pharmacol Ther. 2007;26:953-61.
    PubMed     Related articles    Abstract available
    
    
    
18. VAN DER VEEK PP , VAN Rood YR, Masclee AA
    Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome.
    Aliment Pharmacol Ther. 2007;26:943-52.
    PubMed     Related articles    Abstract available
    
    
    August 2007
19. KLOOKER TK , Kuiken SD, Lei A, Boeckxstaens GE, et al
    Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome.
    Aliment Pharmacol Ther. 2007;26:605-15.
    PubMed     Related articles    Abstract available
    
    
    
20. THABANE M , Kottachchi DT, Marshall JK
    Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome.
    Aliment Pharmacol Ther. 2007;26:535-44.
    PubMed     Related articles    Abstract available
    
    
    
21. GUYONNET D , Chassany O, Ducrotte P, Picard C, et al
    Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.
    Aliment Pharmacol Ther. 2007;26:475-86.
    PubMed     Related articles    Abstract available
    
    
    
22. KAJANDER K , Krogius-Kurikka L, Rinttila T, Karjalainen H, et al
    Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2007;26:463-73.
    PubMed     Related articles    Abstract available
    
    
    
23. JUNG HK , Halder S, McNally M, Locke Iii GR, et al
    Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.
    Aliment Pharmacol Ther. 2007;26:453-61.
    PubMed     Related articles    Abstract available
    
    
    
24. RUBENSTEIN JH , Nojkov B, Korsnes S, Adlis SA, et al
    Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome.
    Aliment Pharmacol Ther. 2007;26:443-52.
    PubMed     Related articles    Abstract available
    
    
    July 2007
25. NYROP KA , Palsson OS, Levy RL, Korff MV, et al
    Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain.
    Aliment Pharmacol Ther. 2007;26:237-248.
    PubMed     Related articles    Abstract available
    
    
    
26. SPIEGEL B , Schoenfeld P, Naliboff B
    Systematic review: the prevalence of suicidal behaviour in patients with chronic abdominal pain and irritable bowel syndrome.
    Aliment Pharmacol Ther. 2007;26:183-193.
    PubMed     Related articles    Abstract available
    
    
    June 2007
27. LEMBO A , Zaman M, Jones M, Talley NJ, et al
    Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study.
    Aliment Pharmacol Ther. 2007;25:1343-50.
    PubMed     Related articles    Abstract available
    
    
    
28. LACY BE , Weiser K, Noddin L, Robertson DJ, et al
    Irritable bowel syndrome: patients' attitudes, concerns and level of knowledge.
    Aliment Pharmacol Ther. 2007;25:1329-41.
    PubMed     Related articles    Abstract available
    
    
    
29. FRISSORA CL , Cash BD
    Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome.
    Aliment Pharmacol Ther. 2007;25:1271-81.
    PubMed     Related articles    Abstract available
    
    
    May 2007
30. CHASSANY O , Bonaz B, Bruley DES Varannes S, Bueno L, et al
    Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol - a randomized, double-blind, placebo-controlled study.
    Aliment Pharmacol Ther. 2007;25:1115-23.
    PubMed     Related articles    Abstract available
    
    
    
31. CHEUNG TK , Lam KF, Hu WH, Lam CL, et al
    Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population.
    Aliment Pharmacol Ther. 2007;25:1099-104.
    PubMed     Related articles    Abstract available
    
    
    April 2007
32. SCARPELLINI E , Gabrielli M, Lauritano CE, Lupascu A, et al
    High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.
    Aliment Pharmacol Ther. 2007;25:781-6.
    PubMed     Related articles    Abstract available
    
    
    March 2007
33. SUH DC , Kahler KH, Choi IS, Shin H, et al
    Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis.
    Aliment Pharmacol Ther. 2007;25:681-92.
    PubMed     Related articles    Abstract available
    
    
    January 2007
34. GAWRONSKA A , Dziechciarz P, Horvath A, Szajewska H, et al
    A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children.
    Aliment Pharmacol Ther. 2007;25:177-84.
    PubMed     Related articles    Abstract available
    
    
    
35. GARRIGUES V , Mearin F, Badia X, Balboa A, et al
    Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study).
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. TENNIS P , Andrews E, Hickman P, Miller D, et al
    The relationship between dosing of alosetron and discontinuation patterns reported by patients participating in a follow-up programme.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
37. NISHIZAWA T , Suzuki H, Nomoto Y, Masaoka T, et al
    Enhanced plasma ghrelin levels in patients with functional dyspepsia.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:104-10.
    PubMed     Related articles    Abstract available
    
    
    September 2006
38. MAYER EA , Tillisch K, Bradesi S
    Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.
    Aliment Pharmacol Ther. 2006;24:919-33.
    PubMed     Related articles    Abstract available
    
    
    
39. JONES R , Latinovic R, Charlton J, Gulliford M, et al
    Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database.
    Aliment Pharmacol Ther. 2006;24:879-86.
    PubMed     Related articles    Abstract available
    
    
    
40. MILLER D , Bennett L, Hollis K, Tennis P, et al
    A patient follow-up survey programme for alosetron: assessing compliance to and effectiveness of the risk management programme.
    Aliment Pharmacol Ther. 2006;24:869-78.
    PubMed     Related articles    Abstract available
    
    
    
41. WILSON S , Maddison T, Roberts L, Greenfield S, et al
    Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome.
    Aliment Pharmacol Ther. 2006;24:769-80.
    PubMed     Related articles    Abstract available
    
    
    
42. MACFARLANE S , Macfarlane GT, Cummings JH
    Review article: prebiotics in the gastrointestinal tract.
    Aliment Pharmacol Ther. 2006;24:701-14.
    PubMed     Related articles    Abstract available
    
    
    August 2006
43. SAAD RJ , Chey WD
    Review article: current and emerging therapies for functional dyspepsia.
    Aliment Pharmacol Ther. 2006;24:475-92.
    PubMed     Related articles    Abstract available
    
    
    July 2006
44. LU CL , Chang FY, Chen CY, Luo JC, et al
    Significance of Rome II-defined functional constipation in Taiwan and comparison with constipation-predominant irritable bowel syndrome.
    Aliment Pharmacol Ther. 2006;24:429-38.
    PubMed     Related articles    Abstract available
    
    
    
45. HEADING R , Bardhan K, Hollerbach S, Lanas A, et al
    Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome - a European perspective.
    Aliment Pharmacol Ther. 2006;24:207-36.
    PubMed     Related articles    Abstract available
    
    
    
46. TACK J , Fried M, Houghton LA, Spicak J, et al
    Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective.
    Aliment Pharmacol Ther. 2006;24:183-205.
    PubMed     Related articles    Abstract available
    
    
    
47. WHITEHEAD WE , Palsson OS, Feld AD, Levy RL, et al
    Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome.
    Aliment Pharmacol Ther. 2006;24:137-46.
    PubMed     Related articles    Abstract available
    
    
    June 2006
48. CHOUNG RS , Locke GR 3rd, Zinsmeister AR, Melton LJ 3rd, et al
    Alternating bowel pattern: what do people mean?
    Aliment Pharmacol Ther. 2006;23:1749-55.
    PubMed     Related articles    Abstract available
    
    
    
49. WILLIAMS RE , Black CL, Kim HY, Andrews EB, et al
    Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome.
    Aliment Pharmacol Ther. 2006;23:1667-75.
    PubMed     Related articles    Abstract available
    
    
    
50. TACK J , Middleton SJ, Horne MC, Piessevaux H, et al
    Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome.
    Aliment Pharmacol Ther. 2006;23:1655-65.
    PubMed     Related articles    Abstract available
    
    
    April 2006
51. MAWE GM , Coates MD, Moses PL
    Review article: intestinal serotonin signalling in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2006;23:1067-76.
    PubMed     Related articles    Abstract available
    
    
    
52. MANGEL AW
    Personal view: adequate relief as a primary endpoint in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2006;23:879-81.
    PubMed     Related articles    Abstract available
    
    
    March 2006
53. MEARIN F , Badia X, Balboa A, Benavent J, et al
    Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
    Aliment Pharmacol Ther. 2006;23:815-26.
    PubMed     Related articles    Abstract available
    
    
    
54. FARESJO A , Grodzinsky E, Foldevi M, Johansson S, et al
    Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers.
    Aliment Pharmacol Ther. 2006;23:807-14.
    PubMed     Related articles    Abstract available
    
    
    February 2006
55. HUSSAIN Z , Quigley EM
    Systematic review: complementary and alternative medicine in the irritable bowel syndrome.
    Aliment Pharmacol Ther. 2006;23:465-71.
    PubMed     Related articles    Abstract available
    
    
    January 2006
56. TACK J , Broekaert D, Corsetti M, Fischler B, et al
    Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man.
    Aliment Pharmacol Ther. 2006;23:265-74.
    PubMed     Related articles    Abstract available
    
    
    
57. WILLIAMS RE , Black CL, Kim HY, Andrews EB, et al
    Stability of irritable bowel syndrome using a Rome II-based classification.
    Aliment Pharmacol Ther. 2006;23:197-205.
    PubMed     Related articles    Abstract available
    
    
    
58. KHOSHOO V , Armstead C, Landry L
    Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome.
    Aliment Pharmacol Ther. 2006;23:191-6.
    PubMed     Related articles    Abstract available
    
    
    December 2005
59. LUPASCU A , Gabrielli M, Lauritano EC, Scarpellini E, et al
    Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.
    Aliment Pharmacol Ther 2005;22.
    PubMed     Related articles    Abstract available
    
    
    
60. VAKIL N , Zanten SV, Chang L, Toth G, et al
    Comprehension and awareness of symptoms in women with dyspepsia.
    Aliment Pharmacol Ther 2005;22.
    PubMed     Related articles    Abstract available
    
    
    
61. WHORWELL PJ
    Review article: the history of hypnotherapy and its role in the irritable bowel syndrome.
    Aliment Pharmacol Ther 2005;22.
    PubMed     Related articles    Abstract available
    
    
    
62. HINDS R , Soondrum K
    Colonoscopy should intubate the terminal ileum.
    Aliment Pharmacol Ther. 2005;22.
    PubMed     Related articles   
    
    
    November 2005
63. LEE KJ , Kim JH, Cho SW
    Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome.
    Aliment Pharmacol Ther 2005;22:981-8.
    PubMed     Related articles    Abstract available
    
    
    
64. ANDREWS EB , Eaton SC, Hollis KA, Hopkins JS, et al
    Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey.
    Aliment Pharmacol Ther 2005;22:935-42.
    PubMed     Related articles    Abstract available
    
    
    
65. LU WZ , Gwee KA, Moochhalla S, Ho KY, et al
    Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study.
    Aliment Pharmacol Ther 2005;22:927-34.
    PubMed     Related articles    Abstract available
    
    
    
66. KILKENS TO , Honig A, Fekkes D, Brummer RJ, et al
    The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.
    Aliment Pharmacol Ther 2005;22:865-74.
    PubMed     Related articles    Abstract available
    
    
    October 2005
67. DUNCAN M , Davison JS, Sharkey KA
    Review article: endocannabinoids and their receptors in the enteric nervous system.
    Aliment Pharmacol Ther 2005;22:667-83.
    PubMed     Related articles    Abstract available
    
    
    September 2005
68. KAJANDER K , Hatakka K, Poussa T, Farkkila M, et al
    A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Aliment Pharmacol Ther 2005;22:387-94.
    PubMed     Related articles    Abstract available
    
    
    
69. VAHEDI H , Merat S, Rashidioon A, Ghoddoosi A, et al
    The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study.
    Aliment Pharmacol Ther 2005;22:381-5.
    PubMed     Related articles    Abstract available
    
    
    
70. REILLY MC , Barghout V, McBurney CR, Niecko TE, et al
    Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.
    Aliment Pharmacol Ther 2005;22:373-80.
    PubMed     Related articles    Abstract available
    
    
    July 2005
71. KANAZAWA M , Fukudo S
    Development of irritable bowel syndrome may be associated with a parental history of bowel problems.
    Aliment Pharmacol Ther 2005;22:166-7.
    PubMed     Related articles   
    
    
    
72. KUIKEN SD , Lindeboom R, Tytgat GN, Boeckxstaens GE, et al
    Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome.
    Aliment Pharmacol Ther 2005;22:157-64.
    PubMed     Related articles    Abstract available
    
    
    June 2005
73. LU CL , Chang FY, Lang HC, Chen CY, et al
    Gender difference on the symptoms, health-seeking behaviour, social impact and sleep quality in irritable bowel syndrome: a Rome II-based survey in an apparent healthy adult Chinese population in Taiwan.
    Aliment Pharmacol Ther 2005;21:1497-505.
    PubMed     Related articles    Abstract available
    
    
    
74. NUCERA G , Gabrielli M, Lupascu A, Lauritano EC, et al
    Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.
    Aliment Pharmacol Ther 2005;21:1391-5.
    PubMed     Related articles    Abstract available
    
    
    
75. HUNGIN AP , Chang L, Locke GR, Dennis EH, et al
    Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
    Aliment Pharmacol Ther 2005;21:1365-75.
    PubMed     Related articles    Abstract available
    
    
    
76. OTAKA M , Jin M, Odashima M, Matsuhashi T, et al
    New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline.
    Aliment Pharmacol Ther 2005;21 Suppl 2:42-6.
    PubMed     Related articles    Abstract available
    
    
    
77. HONGO M , Kanatsuka H, Sugawara A, Nagasaki Y, et al
    Primary care in the treatment of functional gastrointestinal symptoms in Japan: prescription preferences and impression of results.
    Aliment Pharmacol Ther 2005;21 Suppl 2:47-54.
    PubMed     Related articles    Abstract available
    
    
    April 2005
78. MOHAMMED I , Nightingale P, Trudgill NJ
    Risk factors for gastro-oesophageal reflux disease symptoms: a community study.
    Aliment Pharmacol Ther 2005;21:821-7.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: